Globe Newswire
PHILADELPHIA, Oct. 10, 2026 (GLOBE NEWSWIRE) --
Aardvark Therapeutics, Inc. (NASDAQ: AARD):
Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.
What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and... (continue reading...)
WUHU, China, Oct. 10, 2026 (GLOBE NEWSWIRE) -- What happens when a hybrid marathon gets its own BGM, switches to Night Vibe after dark, and even turns into a gaming zone when the car is parked? From October 21 to 22, OMODA & JAECOO is about to deliver an exciting answer.
As a core technology experience of the “DRIVE TO THE NEXT VIBE” International User Summit, taking place from October 19 to 24, the OMODA Super Hybrid Marathon will bring together global media and... (continue reading...)
NEW YORK, Oct. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders, today announced the presentation of four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress, taking place in Munich, Germany from October 10-13, 2026. The... (continue reading...)
BOULDER, Colo., Oct. 10, 2026 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Blink Single-Use Custom Packs offering and a first-of-its-kind automated manufacturing process for Sharpoint® microsurgical knives at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting taking place October 10 - 12 in New Orleans.
These new ophthalmic advancements represent Corza Medical's continued... (continue reading...)
New research spotlights hypoglycemia-related burdens in adults with type 1 diabetes using automated insulin delivery systems
HIGH POINT, N.C., Oct. 10, 2026 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D), today announced that Chief Medical Officer Thomas Strack, M.D., Ph.D., presented research spotlighting hypoglycemia-related... (continue reading...)
More Globe Newswire
View Older Stories-
Tivaro Shares a Guide to Choosing a Lightweight Folding Electric Wheelchair
-
Vannor Launches Agentic Marketing After AI Agents Drive 30-Fold Increase in First-Page Google Rankings
-
Green Thumb Opens RISE Dispensary in Cape Coral, Expanding Florida Footprint to 25 Locations
-
CGTN: How China uses digital tech to empower women globally
-
Sigenergy Unveils the Latest Energy Solutions at Malaysia’s IGEM 2026
-
Island Passage Trenching Confirms Porphyry Copper-Gold System at the EL02 Project, Bougainville Island, Papua New Guinea
-
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
-
Coastal Community Bank Invests in Workforce Housing Through Koz Development's PNW Attainable Workforce Housing Fund
-
Coastal Community Bank Invests in Workforce Housing Through Koz Development's PNW Attainable Workforce Housing Fund
-
Brookfield Infrastructure Corporation Announces New Date for Meeting on Proposed Corporate Simplification
-
Brookfield Renewable Partners Announces New Date for Meeting on Proposed Corporate Simplification
-
KIXO9 Launches a New Digital-First Model for Online Gaming in South Asia
-
Orca Energy Group Provides Update on Songo Songo Licence, Operations, and the Proposed Transaction
-
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disc
-
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disc
-
Justin Sun Shares AI and Quantum Vision at TOKEN2049 Singapore and Blockworks DAS Asia
-
Francoobla Music Issues Final Call for Broadcasters, Major Record Labels and Investors to Bring “AI vs. HI” Global Challenge to the World
-
LigoLab Introduces AI-Assisted Voice Interface for Anatomic Pathology Workflows
-
BlackStone Roofing and Exteriors Reaches 70 Five-Star Google Reviews, Reinforcing Its Reputation as the Most Trusted Company for Roof Replacement Lexington KY
-
HBT Financial, Inc. to Announce Third Quarter 2026 Financial Results on October 26, 2026
-
Crypto News: Remittix Sets Its Final Presale Price at $0.46 as XRP Price Prediction Targets $12 and Cardano’s RealFi Expansion Revives the $1 ADA Dream
-
Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
-
Integra Announces Pricing of Senior Secured Notes
-
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
-
CZR Founder Charlie Rothkopf Outlines Next Growth Phase at TOKEN2049 Singapore
-
Gran Tierra Energy Inc. Stockholders Approve Sale of Colombian and Ecuadorian Businesses
-
Brookfield Corporation to Host Third Quarter 2026 Results Conference Call
-
Axe Compute (NASDAQ: AGPU) to Ring the Nasdaq Stock Market Opening Bell on October 12, 2026
-
Global Power Provides Corporate Update
-
First Commonwealth to Host Third Quarter 2026 Earnings Release Conference Call and Webcast on Wednesday, October 28, 2026
-
Star Bulk Carriers Corp. Announces Renewal of Existing ATM Equity Offering Programs
-
Cavitation Technologies, Inc. Announces Definitive Agreements with BrightFlixx Finance (Luxembourg) S.A. for Aggregate Proposed Cash Consideration of $42 Million
-
LB Pharmaceuticals Reports Inducement Grants to New Employee Under Nasdaq Listing Rule 5635(c)(4)
-
Basel Medical Group Ltd (BMGL) Closes Registered Direct Offering
-
QTREX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement
-
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Base Electron Corp. Confidentially Submits Draft Registration Statement for Proposed Initial Public Offering
-
Dynagas LNG Partners LP Announces Optional Partial Redemption of 9.00% Series A Cumulative Redeemable Preferred Units
-
Avis Budget Group to Announce Third Quarter 2026 Results on November 03, 2026
-
AEON Biopharma Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
-
Artisan Partners Asset Management Inc. Reports September 2026 Assets Under Management
-
EquipmentShare Responds to Inaccurate Short Report
-
Coca-Cola Consolidated, Inc. Announces Fourth Quarter Dividend
-
No Psychedelic Belongs on the Market, Citizens Commission on Human Rights International Tells Regulators
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 30, 2026
-
Alpine Income Property Trust Announces Agreement to Acquire 13-Property Industrial Portfolio for $117.3 Million
-
Universal Health Services, Inc. Announces Date and Time Change for Third Quarter 2026 Earnings Release and Conference Call
-
Fortune Favor Technology Inc. Announces Entering into an Agreement and Plan of Merger with Quantumsphere Acquisition Corporation
-
Star Bulk Announces Strategic Partnership with Hermes World Maritime S.A.
-
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional
